Strategies for the prevention of postoperative recurrence of Crohn's disease

Colorectal Disease

Volumn 15, Issue 12, 2013, Pages 1471-1480

  Yamamoto, T ^a   Watanabe, T ^b  

^a MIE UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Biologic agents; Crohn's disease; Ileocolonoscopy; Postoperative recurrence; Prophylactic medication

Indexed keywords

ADALIMUMAB; AMINOSALICYLIC ACID; AZATHIOPRINE; BUDESONIDE; C REACTIVE PROTEIN; CALGRANULIN; INFLIXIMAB; LACTOFERRIN; MERCAPTOPURINE; MESALAZINE; NITROIMIDAZOLE; PLACEBO; PROBIOTIC AGENT;

AGE; ANTIBIOTIC THERAPY; ARTICLE; BLOOD TRANSFUSION; CAPSULE ENDOSCOPY; COMPUTED TOMOGRAPHIC COLONOGRAPHY; CONTRAST ENHANCEMENT; CROHN DISEASE; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; EARLY INTERVENTION; ECHOGRAPHY; END TO END ANASTOMOSIS; ENTERIC FEEDING; FAMILY HISTORY; GRANULOMA; HUMAN; INCIDENCE; META ANALYSIS; PATIENT MONITORING; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; SEX; SMOKING; SYSTEMATIC REVIEW; THROMBOCYTE COUNT; TREATMENT OUTCOME; WIDE EXCISION;

BIOLOGIC AGENTS; CROHN'S DISEASE; ILEOCOLONOSCOPY; POSTOPERATIVE RECURRENCE; PROPHYLACTIC MEDICATION;

6-MERCAPTOPURINE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; AZATHIOPRINE; COLECTOMY; COLON; COLONOSCOPY; CROHN DISEASE; HUMANS; ILEUM; IMMUNOSUPPRESSIVE AGENTS; INTESTINAL PERFORATION; MESALAMINE; NITROIMIDAZOLES; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RISK FACTORS; SMOKING; TREATMENT OUTCOME;

EID: 84888073340     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/codi.12326     Document Type: Article

References (67)

1. Bernell O, Lapidus A, Hellers G. Risk factors for surgery and postoperative recurrence in Crohn's disease. Ann Surg 2000; 231: 38-45.
2. Cosnes J, Nion-Larmurier I, Beaugerie L, Afchain P, Tiret E, Gendre JP. Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut 2005; 54: 237-41.
3. Yamamoto T. Factors affecting recurrence after surgery for Crohn's disease. World J Gastroenterol 2005; 11: 3971-9.
4. Buisson A, Chevaux JB, Allen PB, Bommelaer G, Peyrin-Biroulet L. Review article: the natural history of postoperative Crohn's disease recurrence. Aliment Pharmacol Ther 2012; 35: 625-33.
5. Ford AC, Sandborn WJ, Khan KJ, Hanauer SB, Talley NJ, Moayyedi P. Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol 2011; 106: 644-59.
6. van Loo ES, Dijkstra G, Ploeg RJ, Nieuwenhuijs VB. Prevention of postoperative recurrence of Crohn's disease. J Crohns Colitis 2012; 6: 637-46.
7. Van Assche G, Dignass A, Panes J et al. European Crohn's and Colitis Organisation (ECCO). The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. J Crohns Colitis 2010; 4: 7-27.
8. Mahid SS, Minor KS, Soto RE, Hornung CA, Galandiuk S. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc 2006; 81: 1462-71.
9. Cottone M, Rosselli M, Orlando A et al. Smoking habits and recurrence in Crohn's disease. Gastroenterology 1994; 106: 643-8.
10. Yamamoto T, Keighley MR. Smoking and disease recurrence after operation for Crohn's disease. Br J Surg 2000; 87: 398-404.
11. Reese GE, Nanidis T, Borysiewicz C, Yamamoto T, Orchard T, Tekkis PP. The effect of smoking after surgery for Crohn's disease: a meta-analysis of observational studies. Int J Colorectal Dis 2008; 23: 1213-21.
12. Greenstein AJ, Lachman P, Sachar DB et al. Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut 1988; 29: 588-92.
13. Simillis C, Yamamoto T, Reese GE et al. A meta-analysis comparing incidence of recurrence and indication for reoperation after surgery for perforating versus nonperforating Crohn's disease. Am J Gastroenterol 2008; 103: 196-205.
14. Hashemi M, Novell JR, Lewis AA. Side-to-side stapled anastomosis may delay recurrence in Crohn's disease. Dis Colon Rectum 1998; 41: 1293-6.
15. zYamamoto T, Bain IM, Mylonakis E, Allan RN, Keighley MR. Stapled functional end-to-end anastomosis versus sutured end-to-end anastomosis after ileocolonic resection in Crohn disease. Scand J Gastroenterol 1999; 34: 708-13.
16. Munoz-Juarez M, Yamamoto T, Wolff BG, Keighley MR. Wide-lumen stapled anastomosis vs. conventional end-to-end anastomosis in the treatment of Crohn's disease. Dis Colon Rectum 2001; 44: 20-6.
17. Simillis C, Purkayastha S, Yamamoto T, Strong SA, Darzi AW, Tekkis PP. A meta-analysis comparing conventional end-to-end anastomosis vs. other anastomotic configurations after resection in Crohn's disease. Dis Colon Rectum 2007; 50: 1674-87.
18. McLeod RS, Wolff BG, Ross S, Parkes R, McKenzie M; Investigators of the CAST Trial. Recurrence of Crohn's disease after ileocolic resection is not affected by anastomotic type: results of a multicenter, randomized, controlled trial. Dis Colon Rectum 2009; 52: 919-27.
19. Karesen R, Serch-Hanssen A, Thoresen BD, Hertzberg J. Crohn's disease: long-term results of surgical treatment. Scand J Gastroenterol 1981; 16: 57-64.
20. Wolff BG, Beart RW Jr, Frydenberg HB, Weiland LH, Agrez MV, Ilstrup DM. The importance of disease-free margins in resections for Crohn's disease. Dis Colon Rectum 1983; 26: 239-43.
21. Adloff M, Arnaud JP, Ollier JC. Does the histologic appearance at the margin of resection affect the postoperative recurrence rate in Crohn's disease? Am Surg 1987; 53: 543-6.
22. Kotanagi H, Kramer K, Fazio VW, Petras R. Do microscopic abnormalities at resection margins correlate with increased anastomotic recurrence in Crohn's disease? retrospective analysis of 100 cases. Dis Colon Rectum 1991; 34: 909-16.
23. Fazio VW, Marchetti F, Church M et al. Effect of resection margins on the recurrence of Crohn's disease in the small bowel: a randomized controlled trial. Ann Surg 1996; 224: 563-71; discussion 571-3.
24. Yamamoto T, Fazio VW, Tekkis PP. Safety and efficacy of strictureplasty for Crohn's disease: a systematic review and meta-analysis. Dis Colon Rectum 2007; 50: 1968-86.
25. Reese GE, Purkayastha S, Tilney HS, von Roon A, Yamamoto T, Tekkis PP. Strictureplasty vs resection in small bowel Crohn's disease: an evaluation of short-term outcomes and recurrence. Colorectal Dis 2007; 9: 686-94.
26. Sachar DB, Wolfson DM, Greenstein AJ, Goldberg J, Styczynski R, Janowitz HD. Risk factors for postoperative recurrence of Crohn's disease. Gastroenterology 1983; 85: 917-21.
27. Poggioli G, Laureti S, Selleri S et al. Factors affecting recurrence in Crohn's disease. Results of a prospective audit. Int J Colorectal Dis 1996; 11: 294-8.
28. Watanabe T, Sasaki I, Sugita A et al. Interval of less than 5 years between the first and second operation is a risk factor for a third operation for Crohn's disease. Inflamm Bowel Dis 2012; 18: 17-24.
29. Simillis C, Jacovides M, Reese GE, Yamamoto T, Tekkis PP. Meta-analysis of the role of granulomas in the recurrence of Crohn disease. Dis Colon Rectum 2010; 53: 177-85.
30. Ferrante M, de Hertogh G, Hlavaty T et al. The value of myenteric plexitis to predict early postoperative Crohn's disease recurrence. Gastroenterology 2006; 130: 1595-606.
31. Sokol H, Polin V, Lavergne-Slove A et al. Plexitis as a predictive factor of early postoperative clinical recurrence in Crohn's disease. Gut 2009; 58: 1218-25.
32. De Cruz P, Kamm MA, Prideaux L, Allen PB, Desmond PV. Postoperative recurrent luminal Crohn's disease: a systematic review. Inflamm Bowel Dis 2012; 18: 758-77.
33. Van Assche G, Dignass A, Reinisch W et al. European Crohn's and Colitis Organisation (ECCO). The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations. J Crohns Colitis 2010; 4: 63-101.
34. Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index: National Cooperative Crohn's Disease Study. Gastroenterology 1976; 70: 439-44.
35. Regueiro M, Kip KE, Schraut W et al. Crohn's disease activity index does not correlate with endoscopic recurrence one year after ileocolonic resection. Inflamm Bowel Dis 2011; 17: 118-26.
36. Walters TD, Steinhart AH, Bernstein CN et al. Validating Crohn's disease activity indices for use in assessing postoperative recurrence. Inflamm Bowel Dis 2011; 17: 1547-56.
37. Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M. Predictability of the postoperative course of Crohn's disease. Gastroenterology 1990; 99: 956-63.
38. Yamamoto T, Umegae S, Matsumoto K, Saniabadi AR. The relationship between endoscopic findings at the proximal site of anastomosis and subsequent clinical relapse following ileal/ileocolonic resection for Crohn's disease: a prospective endoscopic cohort study. Gut 2009; 58 (Suppl 2): A175 (abstract).
39. Biancone L, Onali S, Calabrese E et al. Non-invasive techniques for assessing postoperative recurrence in Crohn's disease. Dig Liver Dis 2008; 40 (Suppl 2): S265-70.
40. Allen PB, De Cruz P, Lee WK, Taylor S, Desmond PV, Kamm MA. Noninvasive imaging of the small bowel in Crohn's disease: the final frontier. Inflamm Bowel Dis 2011; 17: 1987-99.
41. Biancone L, Calabrese E, Petruzziello C et al. Wireless capsule endoscopy and small intestine contrast ultrasonography in recurrence of Crohn's disease. Inflamm Bowel Dis 2007; 13: 1256-65.
42. Castiglione F, Bucci L, Pesce G et al. Oral contrast-enhanced sonography for the diagnosis and grading of postsurgical recurrence of Crohn's disease. Inflamm Bowel Dis 2008; 14: 1240-5.
43. Calabrese E, Petruzziello C, Onali S et al. Severity of postoperative recurrence in Crohn's disease: correlation between endoscopic and sonographic findings. Inflamm Bowel Dis 2009; 15: 1635-42.
44. Gralnek IM, Defranchis R, Seidman E, Leighton JA, Legnani P, Lewis BS. Development of a capsule endoscopy scoring index for small bowel mucosal inflammatory change. Aliment Pharmacol Ther 2008; 27: 146-54.
45. Biancone L, Fiori R, Tosti C et al. Virtual colonoscopy compared with conventional colonoscopy for stricturing postoperative recurrence in Crohn's disease. Inflamm Bowel Dis 2003; 9: 343-50.
46. Sailer J, Peloschek P, Reinisch W, Vogelsang H, Turetschek K, Schima W. Anastomotic recurrence of Crohn's disease after ileocolic resection: comparison of MR enteroclysis with endoscopy. Eur Radiol 2008; 18: 2512-21.
47. Koilakou S, Sailer J, Peloschek P et al. Endoscopy and MR enteroclysis: equivalent tools in predicting clinical recurrence in patients with Crohn's disease after ileocolic resection. Inflamm Bowel Dis 2010; 16: 198-203.
48. Sipponen T, Savilahti E, Kolho KL, Nuutinen H, Turunen U, Färkkilä M. Crohn's disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn's disease activity index and endoscopic findings. Inflamm Bowel Dis 2008; 14: 40-6.
49. Vieira A, Fang CB, Rolim EG et al. Inflammatory bowel disease activity assessed by fecal calprotectin and lactoferrin: correlation with laboratory parameters, clinical, endoscopic and histological indexes. BMC Res Notes 2009; 2: 221.
50. Sipponen T, Björkesten CG, Färkkilä M, Nuutinen H, Savilahti E, Kolho KL. Faecal calprotectin and lactoferrin are reliable surrogate markers of endoscopic response during Crohn's disease treatment. Scand J Gastroenterol 2010; 45: 325-31.
51. Gisbert JP, Bermejo F, Pérez-Calle JL et al. Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse. Inflamm Bowel Dis 2009; 15: 1190-8.
52. Scarpa M, D'Incà R, Basso D et al. Fecal lactoferrin and calprotectin after ileocolonic resection for Crohn's disease. Dis Colon Rectum 2007; 50: 861-9.
53. Lamb CA, Mohiuddin MK, Gicquel J et al. Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn's disease. Br J Surg 2009; 96: 663-74.
54. Doherty G, Bennett G, Patil S, Cheifetz A, Moss AC. Interventions for prevention of post-operative recurrence of Crohn's disease. Cochrane Database Syst Rev 2009; (4): CD006873.
55. Ford AC, Khan KJ, Talley NJ, Moayyedi P. 5-aminosalicylates prevent relapse of Crohn's disease after surgically induced remission: systematic review and meta-analysis. Am J Gastroenterol 2011; 106: 413-20.
56. Peyrin-Biroulet L, Deltenre P, Ardizzone S et al. Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: a meta-analysis. Am J Gastroenterol 2009; 104: 2089-96.
57. Doherty GA, Bennett GC, Cheifetz AS, Moss AC. Meta-analysis: targeting the intestinal microbiota in prophylaxis for post-operative Crohn's disease. Aliment Pharmacol Ther 2010; 31: 802-9.
58. Yamamoto T, Nakahigashi M, Umegae S, Kitagawa T, Matsumoto K. Impact of long-term enteral nutrition on clinical and endoscopic recurrence after resection for Crohn's disease: a prospective, non-randomized, parallel, controlled study. Aliment Pharmacol Ther 2007; 25: 67-72.
59. Yamamoto T, Shiraki M, Nakahigashi M, Umegae S, Matsumoto K. Enteral nutrition to suppress postoperative Crohn's disease recurrence: a five-year prospective cohort study. Int J Colorectal Dis 2013; 28: 335-40.
60. Sorrentino D, Terrosu G, Avellini C, Maiero S. Infliximab with low-dose methotrexate for prevention of postsurgical recurrence of ileocolonic Crohn disease. Arch Intern Med 2007; 167: 1804-7.
61. Regueiro M, Schraut W, Baidoo L et al. Infliximab prevents Crohn's disease recurrence after ileal resection. Gastroenterology 2009; 136: 441-50.
62. Yoshida K, Fukunaga K, Ikeuchi H et al. Scheduled infliximab monotherapy to prevent recurrence of Crohn's disease following ileocolic or ileal resection: a 3-year prospective randomized open trial. Inflamm Bowel Dis 2012; 18: 1617-23.
63. Savarino E, Dulbecco P, Bodini G, Assandri L, Savarino V. Prevention of postoperative recurrence of Crohn's disease by Adalimumab: a case series. Eur J Gastroenterol Hepatol 2012; 24: 468-70.
64. Papamichael K, Archavlis E, Lariou C, Mantzaris GJ. Adalimumab for the prevention and/or treatment of post-operative recurrence of Crohn's disease: a prospective, two-year, single center, pilot study. J Crohns Colitis 2012; 6: 924-31.
65. Aguas M, Bastida G, Cerrillo E et al. Adalimumab in prevention of postoperative recurrence of Crohn's disease in high-risk patients. World J Gastroenterol 2012; 18: 4391-8.
66. Yamamoto T, Umegae S, Matsumoto K. Impact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohn's disease: a prospective pilot study. Inflamm Bowel Dis 2009; 15: 1460-6.
67. Sorrentino D, Terrosu G, Paviotti A et al. Early diagnosis and treatment of postoperative endoscopic recurrence of Crohn's disease: partial benefit by infliximab - a pilot study. Dig Dis Sci 2012; 57: 1341-8.